Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Posted by Editorial Team on Feb 24th, 2025

Shares of Eden Research plc (LON:EDEN – Get Free Report) fell 3.3% on Saturday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The stock has a fifty day moving average of GBX 3.87 and a two-hundred day moving average of GBX 3.95. The stock has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a current ratio of 3.80, a quick ratio of 2.42 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling at Eden Research

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction on Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,362.19). Also, insider Lykele van der Broek bought 256,000 shares of Eden Research stock in a transaction on Thursday, February 6th. The shares were acquired at an average price of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,958.74). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.